This is outside of my specialty, but standards and conduct of clinical research is quite consistent.
http://www.ncbi.nlm.nih.gov/m/pubmed/25487708/
Group allocations may not be blinded, but to ensure the highest standards (validity of results and exclusion of bias) it would be in the interests of those involved that the steps from data collection to statistical analysis will be conducted by investigators who are blinded to treatment allocation. Without burdening HC readers ... if there were no ethics committees to ensure prospective approval, then a scenario might ensue where a mildly positive result is achieved but deemed questionable. Beyond this, there are still several steps before any increase in volume of sales would be observed.
This is not a placebo-controlled trial; the control group is an existing standard. That is, comparing S with S+F.
(Disclosure: I hold no interest in this stock, and am commenting only from a research/scientific perspective.)
- Forums
- ASX - By Stock
- SRX
- Blinded Trial?
Blinded Trial?, page-3
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.5¢ | $40.71K | 229.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2141678 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2268400 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2141678 | 0.175 |
5 | 3072000 | 0.170 |
1 | 18186 | 0.165 |
1 | 100000 | 0.160 |
1 | 387096 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 2104400 | 19 |
0.185 | 127069 | 4 |
0.190 | 73847 | 3 |
0.195 | 500000 | 1 |
0.200 | 208387 | 10 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
SRX (ASX) Chart |